| 1 | Immunomodulatory role of oncogenic alterations in non-small cell lung cancer: a review of implications for immunotherapy | Coautor: Hernández-Pedro N., Ramos-Ramírez M., Caballe-Pérez E., Lucio-Lozada J., et al. | 2025 | CANCER AND METASTASIS REVIEWS | WoS-id: 001414994100001
Scopus-id: 2-s2.0-85218290716
| 2 | 3 |
| 2 | Impact of KRASG12D subtype and concurrent pathogenic mutations on advanced non-small cell lung cancer outcomes | 2ᵒ autor: Hernández-Pedro N., Caballé-Perez E., Ramos-Ramírez M., Barrios-Bernal P., et al. | 2024 | CLINICAL & TRANSLATIONAL ONCOLOGY | Scopus-id: 2-s2.0-85165584269
| 0 | 3 |
| 3 | LKB1 Loss Assessed by Immunohistochemistry as a Prognostic Marker to First-Line Therapy in Advanced Non-Small-Cell Lung Cancer | Coautor: Hernández-Pedro N.Y., Avilés-Salas A., Díaz-García D.A., Lara-Mejía L., et al. | 2023 | CURRENT ONCOLOGY | WoS-id: 000914551700001
Scopus-id: 2-s2.0-85146750085
| 2 | 2 |
| 4 | PD-L1 expression complements CALGB prognostic scoring system in malignant pleural mesothelioma | Coautor: Hernández-Pedro N., Avilés-Salas A., Cabrera-Miranda L., Vargas-Lías D.S., et al. | 2023 | Frontiers in Oncology | WoS-id: 001126533800001
Scopus-id: 2-s2.0-85180133236
| 2 | 3 |
| 5 | Nitroglycerin Plus Whole Intracranial Radiation Therapy for Brain Metastases in Patients With Non-Small Cell Lung Cancer: A Randomized, Open-Label, Phase 2 Clinical Trial | 2ᵒ autor: Hernández-Pedro N., Arrieta O., Maldonado F., Ramos-Ramírez M., et al. | 2023 | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | Scopus-id: 2-s2.0-85127328453
| 0 | 4 |
| 6 | A Novel Combination of Sotorasib and Metformin Enhances Cytotoxicity and Apoptosis in KRAS-Mutated Non-Small Cell Lung Cancer Cell Lines through MAPK and P70S6K Inhibition | Coautor: Hernández-Pedro N., Barrios-Bernal P., Lucio-Lozada J., Ramos-Ramírez M., et al. | 2023 | INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | Scopus-id: 2-s2.0-85149895657
| 0 | 4 |
| 7 | Obesity paradox and lung cancer, metformin-based therapeutic opportunity? | 2ᵒ autor: Hernández-Pedro N., Barrios-Bernal P., Lara-Mejía L., Arrieta O. | 2023 | Oncotarget | Scopus-id: 2-s2.0-85164209671
| 0 | 1 |
| 8 | Will We Unlock the Benefit of Metformin for Patients with Lung Cancer? Lessons from Current Evidence and New Hypotheses | Coautor: Hernandez-Pedro, Norma, Barrios-Bernal, Pedro, Zatarain-Barrón Z.L., Orozco-Morales, Mario, et al. | 2022 | Pharmaceuticals | WoS-id: 000831526200001
Scopus-id: 2-s2.0-85133477421
| 8 | 11 |
| 9 | An update in the use of antibodies to treat glioblastoma multiforme | 1ᵉʳ autor: Hernández-Pedro N.Y., Rangel-López E., Vargas Félix G., Pineda B., et al. | 2013 | Autoimmune Diseases | Scopus-id: 2-s2.0-84888863667
| 0 | 24 |
ID's SCOPUS 